INDICATION AND IMPORTANT SAFETY INFORMATION
TOBI® Podhaler® (Tobramycin Inhalation Powder) 28 mg per capsule is indicated for the management of cystic fibrosis patients with Pseudomonas aeruginosa. ...More
LEARN HOW TOBI® PODHALER® MAY FIT INTO
YOUR PATIENT’S DAYADMINISTERED IN 2 TO 7 MINUTES1,*
- Take 4 capsules for inhalation twice daily: 4 in the morning and 4 in the evening
- The powder from all 4 capsules must be inhaled to receive the full dose of 112 mg
- Inhale 2 times from each capsule in order to empty it
- 28 days on and 28 days off
PORTABLE1,2
- Compact and lightweight
- No refrigeration or power source required
QUICK CLEANUP1
- No disinfection required
- Wipe clean with a dry cloth
* As observed in a randomized, open-label, active controlled study to evaluate safety.
Important Dosing Considerations1
- Patients and caregivers should be initially trained by their healthcare provider on the proper use of TOBI Podhaler
- TOBI Podhaler capsules must not be swallowed
- Capsules are for use with the Podhaler device only
- Capsules are for oral inhalation only
- Each dose of 4 capsules should be taken as close to 12 hours apart as possible; each dose should not be taken less than 6 hours apart
- Capsules should always be stored in the blister card; each capsule should only be removed IMMEDIATELY BEFORE USE
Becky
14 YEARS OLD | High school student
TOBI Podhaler is portable, so Becky can fit it in her purse.
Not an actual patient.

SET TREATMENT EXPECTATIONS
Inform your patients about what to expect while taking TOBI® Podhaler®
Learn moreADMINISTRATION INFORMATION
Administration information and helpful tips for patients taking TOBI® Podhaler®
Learn moreReferences
1. TOBI Podhaler [Prescribing Information, 2020]
2. Geller DE, Weers J, Heuerding S. Development of an inhaled dry-powder formulation of tobramycin using PulmoSphere™ Technology. J Aerosol Med Pulm Drug Deliv. 2011;24(4):175-182.